Reed Elsevier (LON: REL)‘s stock had its “overweight” rating reiterated by equities research analysts at JPMorgan Chase in a research note issued to investors on Friday. They currently have a $10.99 (685 GBX) price target on the stock.

Several other analysts have also recently commented on the stock. Analysts at Sanford C. Bernstein reiterated an “underperform” rating on shares of Reed Elsevier in a research note to investors on Monday. They now have a $6.41 price target on the stock. Separately, analysts at Macquarie reiterated an “underperform” rating on shares of Reed Elsevier in a research note to investors on Friday, November 9th. They now have a $7.99 price target on the stock. Finally, analysts at Jefferies Group reiterated a “buy” rating on shares of Reed Elsevier in a research note to investors on Thursday, November 8th. They now have a $10.15 price target on the stock.

Reed Elsevier opened at 642.50 on Friday. Reed Elsevier has a 52-week low of GBX 466.10 and a 52-week high of GBX 671.21. The company’s market cap is £7.736 billion.

Reed Elsevier PLC is a provider of professional information solutions. As of December 31, 2011, the Company was organized in five business segments: Elsevier, providing scientific, technical and medical information solutions; LexisNexis Risk Solutions, providing risk information and analytics to business and government customers; LexisNexis Legal & Professional, providing legal, tax, regulatory and business information solutions to professionals, business and government customers; Reed Exhibitions, organising trade exhibitions and conferences, and Reed Business Information, providing information and marketing solutions to business professionals.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.